Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kitae Kim

Showing results (271-280 of 314) with videos related to

Pageof 32
Sort By:
Heart and Vessels|October 8, 2018
Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registryYuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation|November 18, 2024
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.
Journal of Cardiology|November 21, 2020
Impact of no, distal, and proximal deep vein thrombosis on clinical outcomes in patients with acute pulmonary embolism: From the COMMAND VTE registryShushi Nishiwaki, Yusuke Morita, Yugo Yamashita, et al.
Journal of Thrombosis and Thrombolysis|July 7, 2019
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registryYuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 25, 2019
Cancer-Associated Venous Thromboembolism in the Real World　- From the COMMAND VTE RegistryJiro Sakamoto, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis|July 6, 2021
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolismYugo Yamashita, Hidewo Amano, Takeshi Morimoto, et al.
Thrombosis Research|May 14, 2020
Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE RegistryYuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Cardiology|July 26, 2022
Optimal quality of vitamin K antagonist therapy in Japanese patients with venous thromboembolismSeiichi Hiramori, Yugo Yamashita, Takeshi Morimoto, et al.
The American Journal of Cardiology|November 21, 2019
Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry)Yusuke Yoshikawa, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2020
Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE RegistryYuji Nishimoto, Yugo Yamashita, Kitae Kim, et al.
Pageof 32

Showing results (271-280 of 314) with videos related to

Sort By:
Pageof 32
Heart and Vessels|October 8, 2018
Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registryYuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation|November 18, 2024
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.
Journal of Cardiology|November 21, 2020
Impact of no, distal, and proximal deep vein thrombosis on clinical outcomes in patients with acute pulmonary embolism: From the COMMAND VTE registryShushi Nishiwaki, Yusuke Morita, Yugo Yamashita, et al.
Journal of Thrombosis and Thrombolysis|July 7, 2019
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registryYuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 25, 2019
Cancer-Associated Venous Thromboembolism in the Real World　- From the COMMAND VTE RegistryJiro Sakamoto, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis|July 6, 2021
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolismYugo Yamashita, Hidewo Amano, Takeshi Morimoto, et al.
Thrombosis Research|May 14, 2020
Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE RegistryYuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Cardiology|July 26, 2022
Optimal quality of vitamin K antagonist therapy in Japanese patients with venous thromboembolismSeiichi Hiramori, Yugo Yamashita, Takeshi Morimoto, et al.
The American Journal of Cardiology|November 21, 2019
Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry)Yusuke Yoshikawa, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2020
Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE RegistryYuji Nishimoto, Yugo Yamashita, Kitae Kim, et al.
Pageof 32